Clinical Improvement and P63-Deficiency Correction in OLP Patients After Photobiomodulation

<b>Background:</b> Oral lichen planus (OLP) is a chronic inflammatory disease associated with the formation of symptomatic lesions in the mouth. P63 is essential for epidermal development and regeneration. Weak expression of this protein has been shown in OLP lesions. Photobiomodulation...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Zaharieva Mutafchieva (Author), Milena Nenkova Draganova (Author), Blagovesta Konstantinova Yaneva (Author), Plamen Ivanov Zagorchev (Author), Georgi Tomchev Tomov (Author)
Format: Book
Published: MDPI AG, 2024-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_01a65e4d3a02489aba2be92d6ff2c2c3
042 |a dc 
100 1 0 |a Maria Zaharieva Mutafchieva  |e author 
700 1 0 |a Milena Nenkova Draganova  |e author 
700 1 0 |a Blagovesta Konstantinova Yaneva  |e author 
700 1 0 |a Plamen Ivanov Zagorchev  |e author 
700 1 0 |a Georgi Tomchev Tomov  |e author 
245 0 0 |a Clinical Improvement and P63-Deficiency Correction in OLP Patients After Photobiomodulation 
260 |b MDPI AG,   |c 2024-10-01T00:00:00Z. 
500 |a 10.3390/dj12110338 
500 |a 2304-6767 
520 |a <b>Background:</b> Oral lichen planus (OLP) is a chronic inflammatory disease associated with the formation of symptomatic lesions in the mouth. P63 is essential for epidermal development and regeneration. Weak expression of this protein has been shown in OLP lesions. Photobiomodulation (PBM) therapy has been reported to reduce OLP symptoms, but its ability to correct the molecular perturbations of the disease has not been studied. This study aimed to evaluate the efficacy of PBM in OLP treatment by evaluating changes in p63 expression and their association with clinical response. <b>Methods:</b> Twenty OLP patients underwent PBM with a diode laser (810 nm), (0.50 W, 30 s, 1.2 J/cm<sup>2</sup>), 3 times weekly for a month. The treatment efficacy index (EI) was calculated based on pain-level values and clinical scores of lesions before and after therapy. Biopsies were taken before and after therapy, analyzed immunohistochemically for p63 expression, and compared with 10 healthy controls. <b>Results:</b> P63 levels in OLP lesions were significantly lower than those in normal oral mucosa. After treatment, the pain level and clinical scores of the lesions decreased significantly. The calculated EI showed PBM effectiveness in 90% of cases. Increased p63 positivity and staining intensity were observed after therapy. <b>Conclusions:</b> The established p63 deficiency in OLP lesions is likely an important molecular mechanism in the pathogenesis of the disease. Laser irradiation at 810 nm increased p63 expression to a level close to that found in the healthy epithelium and significantly improved the symptoms and clinical signs of OLP. All of this determines the effectiveness of PBM therapy in the management of OLP. 
546 |a EN 
690 |a oral lichen planus 
690 |a p63 expression 
690 |a molecular biomarkers 
690 |a photobiomodulation 
690 |a PBM 
690 |a 810 nm diode laser 
690 |a Dentistry 
690 |a RK1-715 
655 7 |a article  |2 local 
786 0 |n Dentistry Journal, Vol 12, Iss 11, p 338 (2024) 
787 0 |n https://www.mdpi.com/2304-6767/12/11/338 
787 0 |n https://doaj.org/toc/2304-6767 
856 4 1 |u https://doaj.org/article/01a65e4d3a02489aba2be92d6ff2c2c3  |z Connect to this object online.